Thursday, July 30, 2020
Biocon Biologics valued at $3.5 billion after Tata Capital's $30 million financing
Through investments in R&D and high-quality manufacturing infrastructure, we are confident of achieving our aspiration of serving 5 million patients through our biosimilars portfolio, CEO Hamachar said https://ift.tt/33dByn4 https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
Former Groq engineers file a lawsuit in Delaware against Groq, alleging the $20B "non-exclusive" acqui-hire deal with Nvidia in 2025 short-changed employees (Financial Times)
Financial Times : Former Groq engineers file a lawsuit in Delaware against Groq, alleging the $20B “non-exclusive” acqui-hire deal with N...
-
Robert Hackett / Fortune : Profile of Kathryn Haun, a former prosecutor who created US' first federal “digital currency task force” a...
-
Amid government scrutiny over its various trade practices, the firm has been able to hold on to a set of consumers looking for cheaper goods...
No comments:
Post a Comment